Clinical trials rely on accurate data. But what if one of the most important variables whether a patient actually takes the medication is based on guesswork? Traditional methods like pill counts, diaries, or verbal confirmation have long been the standard, … Read More
Author Archives: Oksana Pidmogylna
How poor adherence skews clinical trial results and what to do about it
Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In … Read More
Medication adherence VS compliance: what’s the difference and why it matters
You’ll often hear the terms “adherence” and “compliance” used as if they mean the same thing. But in healthcare and clinical research, they carry very different meanings. Understanding that difference can change the way we work with patients, design better … Read More
AARDEX Group and Pill Connect Partner to Advance Dose Selection with Real-Time Adherence Monitoring in Phase 2A Clinical Trial
Liège, Belgium and Manchester, UK; August 2025: AARDEX Group, a global leader in digital medication adherence solutions, and Pill Connect, a pioneer in connected dispensing technology, have announced a strategic partnership to support a multi-cohort Phase 2A dose selection trial. … Read More
What is medication adherence and why does it matter in clinical trials?
Medication adherence is an element of successful clinical research. It refers to the degree to which a patient follows a prescribed medication regimen including when and how often the medication is taken, and whether it is discontinued prematurely. In clinical … Read More
A hammer doesn’t build a house. People do.
Back in 1981 Zanussi, the Italian manufacturer of home appliances, launched one of the most iconic marketing slogans ever – ‘The appliance of science’. Aiming to convey the message that Zanussi appliances were built with a high level of engineering … Read More
New trial protocol guidance: Updated in SPIRIT Guidelines 2025 but falling short on adherence
The Importance of Protocol Design in Drug Development In the early stages of drug development, as the promise surrounding a new therapy builds, there is a palpable sense of the stakes being raised. And when encouraging findings lead to progress … Read More
Critical momentum: Is medication adherence approaching its universal adoption point?
The ‘Don’t Miss a Moment’ campaign – another chapter in the story of medication adherence Years from now, in a future where healthcare is far more digitally embedded than it is today, the date of 27 March 2025 might well … Read More
Taming the black dog: Managing the challenge of poor adherence among patients with depression
Understanding Depression and Its Impact They might not always be easily identifiable, but millions of people across the globe are living with the debilitating symptoms of depression. This common mental disorder is thought to affect around 5% of the world’s … Read More
From Sealed Envelopes to Smart Adherence: Why Clinical Trials Must Embrace Digital Innovation
Introduction: The Role of Innovation in Clinical Trials Nostalgia can trick us into thinking that things were better in the “good old days”. But the world of science is rarely a place where sentimentality should cloud better judgement. Rather, it … Read More